{"@id":"https://bioecon.ru/technology/humanized-mouse-platforms/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/humanized-mouse-platforms/","json":"https://cn.bioecon.ru/api/v1/technology/humanized-mouse-platforms/index.json"},"id":"humanized-mouse-platforms","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/quantec-ltd/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/chitose/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/eversyn-gmbh/","https://bioecon.ru/companies/minicircle/"]},"maturity":8,"name":"全重构人类免疫系统人源化小鼠模型（Hu-Mice，肿瘤免疫与GvHD评价）","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"超免疫缺陷受体宿主小鼠清髓预处理"},{"n":2,"title":"高纯度人脐带血CD34+造血干细胞尾静脉移植"},{"n":3,"title":"多谱系人类白细胞嵌合率流式细胞术动态监测"},{"n":4,"title":"患者来源肿瘤组织异种移植（PDX）免疫联合验证"}],"summary":"利用严重免疫缺陷宿主小鼠（如NSG、NOG品系），通过移植人脐带血来源CD34+造血干细胞（Hu-CD34）或成人外周血单核细胞（Hu-PBMC），在活体内长期稳定重建功能完整的人类T细胞、B细胞、NK细胞及单核巨噬系统，为双抗、抗体偶联药及CAR-T提供关键活体药效与移植物抗宿主病（GvHD）评估模型。","url":"/technology/humanized-mouse-platforms/","verified":"2026-11-22"}